Autophagy Inhibition Enhances the Anti-Tumor Activity of Methylseleninic Acid in Cisplatin-Resistance Human Lung Adenocarcinoma Cells

Cisplatin (DDP)-based chemotherapy remains one of the standard treatment options for patients with advanced lung adenocarcinoma (LUAD), and cisplatin resistance is the biggest challenge to this therapy. Autophagy is also closely associated with chemoresistance in LUAD. Desperately need to find a way...

Descripción completa

Detalles Bibliográficos
Autores principales: Xin, Ming, Gao, Qi, Xiang, Xindong, Xu, Juanjuan, Jiao, Yuhan, Li, Xuan, Zhang, Xianzhen, Jia, Xiuqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110759/
https://www.ncbi.nlm.nih.gov/pubmed/35592418
http://dx.doi.org/10.3389/fphar.2022.890974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110759/
https://www.ncbi.nlm.nih.gov/pubmed/35592418
http://dx.doi.org/10.3389/fphar.2022.890974

Ejemplares similares